HNHA

Cat. No.: IBDI-436558

HNHA is a potent histone deacetylase (HDAC) inhibitor. HNHA arrests the cell cycle at the G1/S phase via p21 induction. HNHA inhibits tumor growth and tumor neovascularization. HNHA may be a potent anti-cancer agent against breast cancer.

Product Details

Target	HDAC | MMP | HIF/HIF Prolyl-Hydroxylase
Molecular Weight	303.42
SMILES	O=C(NO)CCCCCCSC1=CC=C2C=CC=CC2=C1

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.